Explore how generative AI is revolutionizing antibody design, enabling scientists to create precision antibodies with atomic-level accuracy directly on computers.
Explore how Variable Lymphocyte Receptors (VLRs) from lampreys are revolutionizing disease detection, drug delivery, and therapeutic development.
Explore how artificial intelligence is revolutionizing antibody design through deep learning frameworks that hallucinate optimized antibody libraries for targeted therapies.
How scientists are learning to design our immune system's next move through synthetic immunity.
Discover how scientists are engineering E. coli bacteria with chaperonins to produce single-chain variable fragment antibodies more efficiently.